X @Bloomberg
Bloomberg·2026-04-20 13:18
Eli Lilly has agreed to buy Kelonia Therapeutics for as much as $7 billion, gaining access to a potential cutting-edge treatment for blood cancer https://t.co/TDBcbgHIkk ...
Eli Lilly has agreed to buy Kelonia Therapeutics for as much as $7 billion, gaining access to a potential cutting-edge treatment for blood cancer https://t.co/TDBcbgHIkk ...